Skip to content

News & Blog


Industry News: FDA Breakthrough Device Designation for the Phoenix ® – Revolutionary Transcutaneous Auricular Vagus Nerve Therapy to Treat PTSD

The Phoenix ® is an earbud that delivers a light electrical tingle to activate your vagus nerve, which has a calming effect on the body and helps reduce the symptoms of PTSD.
Read More

The Trial Master File 10 Essentials for Success

A Trial Master File (TMF) is a collection of all essential trial documentation that enables effective monitoring, data integrity, and compliance throughout the lifecycle of a clinical trial. Learn about best practices and approaches for Trial Master File management.
Read More

PharmaVoice Interview with Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium (AGICC)

Watch the PharmaVoice One on One video interview below to learn more about the latest in Gastrointestinal Cancer research from Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium and Division Head of Medical Oncology at the University of Colorado Cancer Center.
Read More

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

The U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).
Read More

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19.
Read More

Positive Preclinical Data for SARS-CoV-2 Nose Spray Vaccine

Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 has significant advantages over injectables
Read More